Validity and Reliability of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) in Adolescents With Idiopathic Scoliosis
Assessment of Exercise Motivation in Adolescent Idiopathic Scoliosis: Validity and Reliability Study of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)
1 other identifier
observational
95
1 country
1
Brief Summary
Adolescent idiopathic scoliosis (AIS) is a spinal condition that develops during adolescence and often requires long-term conservative treatment, including scoliosis-specific therapeutic exercises. The success of exercise-based treatment largely depends on adolescents' motivation to start and continue exercising. However, exercise motivation has not been adequately evaluated in adolescents with idiopathic scoliosis using validated tools specific to this population. The Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) is a widely used questionnaire based on Self-Determination Theory that assesses different types of motivation toward exercise. Although the Turkish version of the BREQ-2 exists, its validity and reliability have not yet been examined in adolescents with idiopathic scoliosis. The purpose of this study is to evaluate the validity and reliability of the Turkish version of the BREQ-2 in adolescents diagnosed with idiopathic scoliosis. Adolescents aged 10-19 years who have been participating in scoliosis-specific therapeutic exercise programs for at least two months will be invited to complete online questionnaires. The results of this study will help determine whether the BREQ-2 is an appropriate tool for assessing exercise motivation in this population and may support the development of individualized motivational strategies in scoliosis rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2026
CompletedFirst Submitted
Initial submission to the registry
January 13, 2026
CompletedFirst Posted
Study publicly available on registry
January 22, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
January 28, 2026
January 1, 2026
8 months
January 13, 2026
January 26, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Validity and Reliability of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2)
The primary outcome is the psychometric evaluation of the Turkish version of the Behavioral Regulation in Exercise Questionnaire-2 (BREQ-2) in adolescents with idiopathic scoliosis, including internal consistency, test-retest reliability, and criterion-related validity.
Baseline assessment; test-retest reliability assessed over a 2-week interval
Study Arms (1)
Adolescents With Idiopathic Scoliosis
Adolescents aged 10-19 years diagnosed with adolescent idiopathic scoliosis who have been receiving scoliosis-specific exercise therapy for at least two months and who voluntarily participate in the study.
Interventions
No intervention is administered. Participants complete self-reported questionnaires (BREQ-2, QPSSE motivation subscale, and EMI-2) for the assessment of exercise motivation.
Eligibility Criteria
The study population consists of adolescents aged 10 to 19 years who have been diagnosed with adolescent idiopathic scoliosis and are currently receiving scoliosis-specific exercise-based physiotherapy.
You may qualify if:
- Aged between 10 and 19 years
- Diagnosed with adolescent idiopathic scoliosis
- Receiving scoliosis-specific therapeutic exercise treatment for at least 2 months
- Able to read and write in Turkish
- Volunteered to participate in the study and provided informed consent
You may not qualify if:
- Presence of congenital or neuromuscular scoliosis
- Presence of systemic disease
- Presence of syndromic conditions such as Marfan syndrome or Ehlers-Danlos syndrome
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nigde Omer Halisdemir University
Niğde, Niğde Province, Turkey (Türkiye)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer
Study Record Dates
First Submitted
January 13, 2026
First Posted
January 22, 2026
Study Start
January 1, 2026
Primary Completion (Estimated)
September 1, 2026
Study Completion (Estimated)
December 1, 2026
Last Updated
January 28, 2026
Record last verified: 2026-01